207
Participants
Start Date
October 16, 2018
Primary Completion Date
March 5, 2020
Study Completion Date
July 18, 2020
Clonidine Micropellets
Injection
Sham
Injection
Sollis Clinical Study Site 25, Albany
Sollis Clinical Study Site 31, Rochester
Sollis Clinical Study Site 30, Washington D.C.
Sollis Clinical Study Site 23, Morgantown
Sollis Clinical Study Site 18, Winston-Salem
Sollis Clinical Study Site 38, Miami
Sollis Clinical Study Site 35, Fort Lauderdale
Sollis Clinical Study Site 36, Mobile
Sollis Clinical Study Site 10, Edgewood
Sollis Clinical Study Site 21, Cleveland
Sollis Clinical Study Site 33, Cleveland
Sollis Clinical Study Site 27, Madison
Sollis Clinical Study Site 13, Chicago
Sollis Clinical Study Site 17, Shrewsbury
Sollis Clinical Study Site 12, Bloomington
Sollis Clinical Study Site 14, Kansas City
Sollis Clinical Study Site, Overland Park
Sollis Clinical Study Site 19, Edmond
Sollis Clinical Study Site, Dallas
Sollis Clinical Study Site 20, Tyler
Sollis Clinical Study Site 34, Houston
Sollis Clinical Study Site 43, The Woodlands
Sollis Clinical Study Site 22, San Antonio
Sollis Clinical Study Site 47, Salt Lake City
Sollis Clinical Study Site #41, Phoenix
Sollis Clinical Study Site #44, Phoenix
Sollis Clinical Study Site 29, Scottsdale
Sollis Clinical Study Site 40, Tucson
Sollis Clinical Study Site 49, Rancho Mirage
Sollis Clinical Study Site 28, Santa Rosa
Sollis Clinical Study Site 46, Eugene
Sollis Clinical Study Site 16, Boston
Sollis Clinical Study Site 15, Brookline
Collaborators (1)
Lotus Clinical Research, LLC
OTHER
Sollis Therapeutics, Inc.
INDUSTRY